Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies. Researchers led by ...

Perovskite solar cells are a high-efficiency, low-cost alternative to traditional silicon-based solar panels. With the perovskite solar cell industry expected to reach $1.2 billion by 2033 ...

When Bruce Levine and his colleagues began attempting to engineer immune cells to fight cancer in the 1990s, few people thought they would succeed. “The wider community was very sceptical ...

Fuel cells powered with the metal could provide a new source of electric power that's far more energy-dense than lithium-ion batteries. A new type of fuel cell that runs on sodium metal could one ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

Candid's T-cell engager shopping spree rolls on with WuXi Biologics pact worth up to $925M As for Juri, very little is publicly known about the TCG Labs Soleil-created company.